drugset
drugset / Trial / NCT01911754

Japanese Pediatric H5N1 Vaccine Study

NCT01911754 ↗

Phase 3 Completed 60 enrolled Alachua Government Services, Inc. Baxter Innovations GmbH · collab
NaSingle-groupOpen-labelPrevention

Summary

The purpose of this study is to obtain immunogenicity and safety data of an H5N1 pandemic influenza vaccine in a Japanese pediatric population aged 6 months to 17 years

Timeline

Start
2013-08
Primary completion
2013-11
Completion
2014-04

Drugs

EvaluationDrugModalityDoseRoute
Subject H5N1 (Pre-)Pandemic Influenza Vaccine Vaccine 0.5 ml Intramuscular

Indications

influenza